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Abstract and keywords 
Abstract: The role of primary care physicians (PCP) in Hepatitis C Virus (HCV) prevention is 
increasingly emphasized. Yet, little is known about the patterns of contacts with PCP among 
persons who inject drugs (PWID). We sought to assess the six-month prevalence of PCP visiting 
among PWID at risk of HCV infection, and to explore the associated factors. Baseline data were 
collected from HCV-seronegative PWID recruited in HEPCO, an observational Hepatitis Cohort 
study (2004-2011) in Montreal, Canada. An interviewer-administered questionnaire elicited 
information on socio-demographic factors, drug use patterns, and health care services utilization. 
Blood samples were tested for HCV antibodies. Using the Gelberg-Andersen Behavioral Model, 
hierarchical logistic regression analyses were conducted to identify predisposing, need and 
enabling factors associated with PCP visiting. Of the 349 participants (mean age=34; 80.8% 
male), 32.1% reported visiting a PCP. In the multivariate model, among predisposing factors, 
male gender (Adjusted Odds Ratio [AOR]=0.45, [0.25-0.83], chronic homelessness (AOR=0.08, 
[0.01-0.67]), cocaine injection (AOR=0.46, [0.28-0.76]) and reporting greater illegal or semi-
legal income (AOR=0.48, [0.27-0.85]) were negatively associated with PCP visits. Markers of 
need were not associated with the outcome. Among enabling factors, contact with street nurses 
(AOR=3.86, [1.49-9.90]) and food banks (AOR=2.01, [1.20-3.37]) were positively associated 
with PCP visiting. Only one third of participating PWID reported a recent visit to a PCP. While a 
host of predisposing factors seems to hamper timely contacts with PCP among high-risk PWID, 
community-based support services may play an important role in initiating dialogue with primary 
health care services in this population. 
Keywords: hepatitis C, drug use, injection, primary care, physician 
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Abbreviations 
HCV: Hepatitis C Virus 
HIV: Human Immunodeficiency Virus  
NEP: needle exchange programs  
PCP: primary care physician 
PWID: persons who inject drugs 
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Introduction 
In developed countries, illicit injection drug use is at the core of the Hepatitis C epidemic, 
accounting for the majority of new (80%) and existing (60%) infections (1, 2). Currently, there is 
no vaccine available to confer protection against infection with Hepatitis C Virus (HCV) (3), and 
therefore, prevention is dependent upon efforts to decrease transmission rates among high-risk 
persons. Recent guidelines issued by the Centers for Disease Control and Prevention (CDC) in 
the United States recommend the provision of a comprehensive HCV prevention approach, 
involving multiple, combined strategies, among persons who inject drugs (PWID) (4). 
Chronic disease prevention is an integral component of primary health care services, and 
primary care physicians (PCP) have a well-established role in offering preventive care for 
chronic illnesses such as type II diabetes, cardiovascular diseases, and alcohol use disorders (5, 
6). Increasingly emphasized is the role that PCP may play in curbing the HCV epidemic through 
key HCV prevention interventions, including screening, counseling and testing (7, 8). These 
strategies are recommended by the United States CDC on a regular basis among high-risk 
persons (4), as they are shown to reduce risky injection behaviors (9, 10). Yet, a considerable 
proportion of PWID are not aware of being infected (11), and patients without a regular source 
of care are nearly 20 times more likely to be unaware of their infection (12). Further, as HCV 
therapy can reduce the reservoir of HCV-infected PWID and prevent further infections, the value 
of treatment as prevention is increasingly recognized (13). With the advent of well-tolerated, 
orally administered HCV treatment regimens (14), it is likely that PCP will be able to effectively 
deliver HCV therapy as part of integrated health care settings (15).  
Despite being at high risk of HCV infection (16), PWID are less likely to benefit from 
primary preventive health care compared to the general population (17). A complex interplay of 
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factors is known to be at the root of health care services use, in general, among PWID, ranging 
from individual circumstances to provider- and system-related factors (18-21). Little is known, 
however, about the factors influencing visits to PCP in this population. In West Yorkshire, 
England, fear of negative provider attitudes and difficulties travelling to services among those 
living in rural areas were reported as barriers by PWID trying to secure primary health care (22). 
Conversely, contact with needle exchange programs (NEP) among PWID in Baltimore was 
identified as a significant facilitator to primary health care visits (23).  
In an effort to enhance our understanding of the patterns of contacts with primary health 
care services among PWID at risk of HCV infection, and help direct efforts toward improving 
HCV prevention in this population, we examined the six-month prevalence of visiting a PCP, 
and factors that may deter or enhance visits in a sample of HCV-seronegative PWID living in a 
large, urban Canadian city.  
Methods 
Study population 
The study population was drawn from the Saint- Luc Cohort, an open cohort of PWID 
established in Montreal in 1988 to study determinants of Human Immunodeficiency Virus (HIV) 
transmission. In 2004, the study’s objectives were expanded to include a focus on determinants 
of HCV, and the HEPatitis COhort (HEPCO), an embedded cohort of HCV-seronegative PWID, 
was constituted. To be eligible for recruitment into HEPCO, participants are required to be 
current PWID (i.e., having injected drugs within the previous six months), be negative for HCV 
infection, and at least 18 years of age. 
A detailed description of the recruitment and follow-up procedures has been previously 
published (24). HEPCO includes HCV-seronegative participants already followed in the Saint-
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Luc cohort (30%), as well as new participants recruited through street-level strategies such as 
word-of-mouth (36%) or through community program referrals (34%). All participants signed an 
informed consent in compliance with institutional review board regulations of the Centre 
Hospitalier de l’Université de Montréal (CHUM).  
We used baseline data collected from 349 HCV-seronegative HEPCO participants 
recruited between November 2004 and March 2011. At enrollment, an interviewer-administered 
questionnaire elicited information on socio-demographic factors, patterns of drug use and related 
behaviors, health status and health care services utilization. Venous blood samples were 
collected for HCV testing. Participants were encouraged to return for their test results two weeks 
post-interview, at which time appropriate counseling and referrals were provided. A CAD 15.00$ 
stipend was offered to all participants upon completion of the questionnaire, as compensation for 
their time. This study was approved by the Ethics Committee of the Centre de Recherche du 
CHUM.   
Measures 
The outcome variable was a self-reported dichotomous measure of having visited one or 
more PCP in a public or private-funded clinic in reference to the previous six months. All PCP 
visits in Montreal are entirely covered by the provincial health insurance. To guide variable 
selection and classification, we relied on the Gelberg-Andersen Behavioral Model for Vulnerable 
Populations (25). This framework has provided a foundation for studies of utilization of out-
patient medical care (26), antiretroviral treatment for HIV (27) and drug treatment (28) among 
vulnerable groups. According to the model, an individual’s use of health care services is a 
function of three factors: predisposing, need and enabling. Predisposing factors refer to an 
individual’s general propensity to seek health care services. Need characteristics reflect an 
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individual’s health status and perception of illness. Enabling factors include community 
resources that enable individuals’ access to needed health care services.  
Predisposing factors included age, gender and education, and markers of vulnerability 
that are relevant to the study population such as chronic homelessness, intravenous cocaine use 
and reporting a greater proportion of the income coming through unstable sources. Consistent 
with the definition given by the Substance Abuse and Mental Health Services Administration 
(29), chronic homelessness was defined as sleeping in shelters every night for the past six 
months. Participants were considered to have greater unstable income if they reported obtaining 
greater income through semi-legal (e.g., prostitution, panhandling) or illegal (e.g., selling drugs) 
sources than through regular, legal employment positions or governmental benefits. Need factors 
were assessed by means of perceived health status and reports of being sick. Enabling factors 
included contacts with community-based support programs such as street nurses, recovery 
centers for drug misuse, NEP and food banks.  
Statistical analyses 
We used descriptive statistics (i.e., means, standard deviations (SD) and frequency 
distributions) to characterize the study population, and bivariate logistic regression analyses to 
examine the association between visits to PCP and each correlate. To explore factors that were 
independently associated with PCP visits, and to determine the influence of each of the three 
predictor domains on the outcome, we constructed a hierarchical multivariate logistic regression 
model, whereby blocks of variables, informed by our conceptual framework, were entered in a 
sequential manner (30). Specifically, predisposing variables were entered first and were 
followed, sequentially, by need, and enabling factors. Each time a set of variables of a particular 
domain was entered, we chose the most parsimonious model (p<0.1) through a process of 
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stepwise backward elimination, and then the next set of variables was entered. The variables age 
and gender were forced into the multivariate models. The change in the -2 log likelihood 
statistic, induced by the addition of each variable block, was indicative of the relative 
contribution made by that specific predicting domain (30). Model fit was assessed using the 
likelihood ratio test. All analyses were performed using SAS® v 9.3 (SAS Institute, Cary, North 
Carolina, United States).   
Results 
At enrollment, participants’ mean age was 34 (SD= 9.6) and 80.8% were male. A 
minority reported having completed a college education (16.0%) and being chronically homeless 
(6.9%). One hundred and twelve (32.1%) reported visits to a PCP in the previous six months.  
Table 1 presents descriptive and bivariate logistic regression analyses between PCP visits 
and each correlate. Among predisposing factors, male gender, chronic homelessness, cocaine 
injection and reporting greater unstable income were negatively associated with PCP visits. 
Perceived health and reports of being sick, markers of need, were not associated with the 
outcome. Among enabling factors, contact with street nurses and contact with food banks were 
positively associated with visits to PCP. 
Results from the hierarchical multivariate logistic regression model are presented in 
Table 2. Compared to the intercept-only model, the introduction of the predisposing domain in 
Model A significantly improved model fit, as illustrated by the likelihood ratio test (p<0.0001). 
Male gender, chronic homelessness, cocaine injection and reporting a greater proportion of the 
income coming through unstable sources remained independently associated with visiting a PCP. 
Need variables did not meet the criterion for retention into the multivariate model (i.e., p<0.1) 
and thus, Model B yielded results identical to Model A. The addition of the enabling set of 
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variables in Model C significantly improved model fit (p<0.0001). Contact with street nurses and 
contact with food banks remained independently associated with visiting a PCP.  
In the final multivariate model, variables that remained significantly associated with PCP 
visits included male gender, chronic homelessness, cocaine injection, reporting greater income 
through unstable sources, contact with street nurses and contact with food banks. 
Discussion 
Our study documents a low proportion of recent visits to a PCP among HCV-
seronegative PWID. Only one third of participants reported having visited a PCP in the previous 
six months. In contrast, nationwide surveys conducted in Canada (31) and the United States (32) 
noted that over 90% of Canadians and 67% of Americans have a regular source of health care. 
Previous research conducted in Florida illustrated that, compared to non-drug users, PWID are 
nearly half as likely to receive a routine physical exam (17). Altogether, these findings suggest 
that PWID are substantially less likely to benefit from primary, preventive health care, as 
delivered by PCP, despite their elevated risk of morbidity and mortality (33), even when covered 
by a universal health insurance plan.  
Given an estimated HCV incidence rate as high as 25 per 100 person-years among recent-
onset injectors (34), there is a narrow window of opportunity to intervene. It has been postulated 
that current harm reduction programs, although effective, may not reach PWID early enough in 
their ‘injecting careers’ to optimally impact HCV transmission (35). Timely contacts with PCP 
presents an opportunity to intervene early by offering HCV screening, counseling and testing, 
hence also a venue for evaluation and intervention for drug misuse (36) and continuity of care,  
strategy that is key to an effective HCV prevention approach (4). 
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Following the Gelberg-Andersen Behavioral Health Model, our study indicates that 
several predisposing and enabling factors, but not need, may be important in shaping the patterns 
of contacts with PCP among HCV-seronegative PWID. Among predisposing factors, male 
gender correlated with lower odds of visiting a PCP, finding that is consistent with the broader 
literature characterizing gender differences in health-seeking behaviors (37). Cocaine injectors 
were found to be significantly less likely to have visited a PCP. Similarly, PWID who are 
chronically homeless and those who rely heavily on inconsistent income-generating sources had 
significantly reduced odds of reporting visits to a PCP. These findings are open to several 
interpretations. Injection of cocaine has been associated with compulsive drug-seeking behaviors 
and reduced concerns about self-care (38, 39), thus raising the possibility that the observed 
negative association with PCP visiting may be a reflection of their more drug-affected lifestyle. 
PWID who are homeless and who draw substantially from semi-legal and illegal income sources 
are exposed to risk environments previously shown to be associated with poorer health status and 
outcomes among drug-using populations (40). Hence, drug procurement, seeking basic survival 
needs and generating revenue for drug expenses may take priority over obtaining timely, 
preventive health care among these injector sub-groups. Conversely, our findings could also 
reflect a level of reluctance among more disadvantaged sub-groups of PWID to seek help from 
PCP because of anticipated stigma or previous discriminating experiences. An abundant 
literature has documented the stigma that PWID are frequently faced with during encounters 
with health care providers, in particular non-addiction specialists such as PCP, and its negative 
impact on this population’s use of health care services (20-22). 
The absence of a statistically significant association between need factors and PCP 
visiting can be seen through a similar lens. Previous research has shown that PWID often 
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postpone seeking needed care until their conditions become severe, at which point they rely on 
acute health care services (41) . Likewise, this finding could also reflect fear of judgmental 
attitudes and mistrust in the knowledge and capacity of PCP to address the complex health and 
social needs commonly accompanying injection drug use. Indeed, these perceptions may have 
had a negative impact on PWID’s patterns of visits to PCP to the point of rendering need 
insignificant (20, 22). Surveys conducted among PCP illustrated a number of potential 
knowledge deficits in relation to HCV identification and management (42, 43), which has not 
gone unnoticed among PWID (44). Research has indicated, however, that PCP are willing to take 
on a greater role in HCV prevention and care, though additional support for HCV evaluation and 
management is needed (45). To this end, increasing evidence is illustrating that relatively simple 
interventions, such as clinical reminders, can be helpful in improving HCV screening and testing 
rates in primary health care settings (46).  
Our study identified certain interventions that could serve to increase engagement in 
primary care among PWID at risk of HCV infection. We noted that, among enabling factors, 
contacts with food banks and street nurses were associated with two, and nearly four fold greater 
odds of reporting visits to a PCP, respectively. This finding is consistent with previous research 
showing that community-based outreach models can play a key role in engaging vulnerable and 
hard-to-reach populations into primary care (47). Interactions with community-based 
organizations are often perceived as being more trustful and less discriminating by PWID (44), 
and the importance of a trusting relationship between the patient and health care professional as a 
means of encouraging engagement in care in this population has been well documented (48). 
Hence, contacts with food banks and street nurses may serve as an opportunity to attract and 
engage “hard-to-reach” individuals, and to provide facilitated linkage to PCP who are likely to 
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care for drug-using populations. In contrast to findings reported previously in Baltimore (23), 
contact with NEP was not associated with PCP visiting in our study. Typically, in Montreal, NEP 
do not have PCP directly affiliated to their service and working on-site. Further, in contrast to 
outreach nurses and food banks, which generally provide services to PWID during daytime, NEP 
operate mostly at night, which may result in fewer opportunities to establish direct linkage to 
PCP. Altogether, our findings suggest that low-threshold services, by and large, could play an 
important role in initiating dialogue between PWID and primary health care services. Strategies 
to improve direct linkage between NEP and PCP services should be examined.  
Our study presents strengths and limitations. This investigation had a focus on an HCV-
seronegative sample of PWID, which constitutes a focal target group of HCV-prevention 
strategies. In addition, the study was conducted in a large, cosmopolitan North-American city, 
and thus, it may reflect patterns of contacts with PCP among PWID in similar settings. However, 
given the cross-sectional nature of our study, the temporality of associations cannot be 
established. Further, while socio-demographic characteristics are, by and large, reflective of the 
PWID population in Quebec (49), the HEPCO cohort is not a random sample, thereby limiting 
the generalisability of our findings. As in all studies involving PWID, social desirability bias 
might arise as a result of eliciting information on socially sensitive behavior, although research 
has indicated that self-reported data collected from drug-using populations are, by and large, 
reliable and valid (50). Lastly, this study relied on secondarily collected data and therefore, other 
potentially important correlates of PCP visits, such as PWID’s attitudes toward PCP, have not 
been explored. 
In conclusion, although timely visits to PCP may provide an opportunity for HCV 
prevention among HCV-seronegative PWID, our results indicate that this opportunity is 
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frequently missed. As several factors seem to play a role in shaping the patterns of contacts with 
PCP in this population, multiple approaches to promote engagement in care are needed. For one, 
efforts should attend to the broader contextual environment of PWID. Supportive services 
addressing difficulties such as homelessness and lack of a stable employment may give PWID 
the needed stability to be able to focus on their health problems or seek preventive care. Further, 
promoting targeted skill-building training for PCP, as it has been consistently emphasized in 
previous work, could potentially have considerable impacts on their willingness to promote and 
provide timely preventive health care to PWID. In parallel, exchanges with community-based 
support services, including outreach nurses, could serve as a valuable strategy to open up 
dialogue between PCP and this vulnerable population, though further research in exploring this 
matter is needed.  
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Table 1: Descriptive characteristics, unadjusted odds ratios (UOR) and corresponding 95% 
Confidence Intervals (CI) for visiting a primary care physician (PCP) according to predisposing, 
need and enabling factors among 349 HCV-seronegative persons who inject drugs  
 
 
 
Variable 
 
 
Category 
 
Total 
N=349 
n (%) 
Visited a 
PCP 
(N=112) 
n (%) 
 
 
UOR 
 
 
95% CI 
Predisposing factors      
Age Mean (SD+) 34.1 (9.6) 34.5 (10.1) 1.06 0.84 - 1.34 
Gender Male 282 (80.8) 78 (69.6) 0.37 0.22 - 0.64 
 Female 67 (19.2) 34 (30.4) Ref  
Married/common law Yes 34 (9.7) 16 (14.3) 2.03 0.99 - 4.15 
 No 315 (90.3) 96 (85.7) Ref  
Completed college 
education 
Yes 56 (16.0) 22 (19.6) 1.46 0.81 - 2.64 
 No 293 (84.0) 90 (80.4) Ref  
Chronically homeless 
a 
Yes 24 (6.9) 1 (0.9)  0.08 0.01 - 0.63 
 No  325 (93.1) 111 (99.1) Ref  
Cocaine injection b Yes 210 (60.2) 52 (46.4) 0.43 0.27 - 0.69 
 No  139 (39.8) 60 (53.6) Ref  
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Unstable income > 
stable income a 
Yes 117 (33.5) 27 (24.1) 0.52 0.32 - 0.86 
 No  232 (66.5) 85 (75.9) Ref  
Need factors      
Perceived health Excellent/ 
good 
247 (70.8) 72 (64.3) 0.64 0.39 - 1.03 
 Fair/poor 102 (29.2) 40 (35.7) Ref  
Having been sick a Yes 157 (45.0) 55 (49.1) 1.28 0.81 - 2.01 
 No  192 (55.0) 57 (50.9) Ref  
Enabling factors      
Contact with street 
nurses a 
Yes 24 (6.9) 12 (10.7) 2.25 0.98 - 5.18 
 No  325 (93.1) 100 (89.3) Ref  
Contact with recovery 
centers for drug 
misuse a 
Yes 47 (13.5) 22 (19.6) 2.07 1.11 - 3.87 
 No  302 (86.5) 90 (80.4) Ref  
Contact with needle 
exchange programs a 
Yes 203 (58.2) 70 (62.5) 1.30 0.82 - 2.07 
 No  146 (41.8) 42 (37.5) Ref  
Contact with food 
banks a 
Yes 101 (28.9) 47 (42.0) 2.45 1.51 - 3.97 
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  No  248 (71.1) 65 (58.0) Ref   
 
+SD: Standard deviation 
a Refers to behaviors in the past six months 
b Refers to behavior in the past month 
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Table 2: Adjusted odds ratios (AOR) and 95% Confidence Intervals (CI) for visiting a primary 
care physician according to predisposing, need and enabling factors, among 349 HCV- 
seronegative persons who inject drugs  
 
 
 
Variable 
Model A 
(Predisposing 
factors) 
AOR (95% CI)  
Model B 
(Predisposing and 
need factors) 
AOR (95% CI) 
Model C 
(Predisposing, need and 
enabling factors) 
AOR (95% CI) 
Age (10-unit 
increments) 
1.14 (0.88 - 1.49) 1.14 (0.88 - 1.49) 1.12 (0.86 - 1.47) 
Male gender 0.41 (0.23 - 0.74)** 0.41 (0.23 - 0.74)** 0.45 (0.25 - 0.83)* 
Chronically 
homeless a 
0.09 (0.01 - 0.72)* 0.09 (0.01 - 0.72)* 0.08 (0.01 - 0.67)* 
Cocaine injection b 0.50 (0.31 - 0.80)** 0.50 (0.31 - 0.80)** 0.46 (0.28 - 0.76)** 
Unstable income > 
stable income a 
0.54 (0.32 - 0.93)* 0.54 (0.32 - 0.93)* 0.48 (0.27 - 0.85)* 
Contact with street 
nurses a 
- - 3.86 (1.49 - 9.90)** 
Contact with food 
banks a 
- - 2.01 (1.20 - 3.37)** 
-2 log likelihood 397.35 397.35 381.83 
 -2 log likelihood  39.12 0 15.52 
p-value + <0.0001 - <0.0001 
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+ p-value according to the Likelihood ratio test 
a Refers to behaviors in the past six months 
b Refers to behavior in the past month 
* If p<0.05; ** if p<0.01  
 
 
 
 
 
 
 
